Evidence map›Paper›PMID 31543947›Full record

ArticleF1000Research2018

epiflows: an R package for risk assessment of travel-related spread of disease.

Paula Moraga, Ilaria Dorigatti, Zhian N Kamvar, Pawel Piatkowski, Salla E Toikkanen, V P Nagraj, Christl A Donnelly, Thibaut Jombart

Abstract read
In one paragraph

Article in F1000Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Yellow fever in Asia-a risk analysis.Journal of travel medicine · 2021
    Article
  6. Outbreak analytics: a developing data science for informing the response to emerging pathogens.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2019
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Paula MoragaDepartment of Mathematical Sciences, University of Bath, Bath, BA2 7AY, UK.ORCID 0000-0001-5266-0201
Ilaria Dorigatti *MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College, London, W2 1PG, UK.ORCID 0000-0001-9959-0706
Zhian N Kamvar *MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College, London, W2 1PG, UK.ORCID 0000-0003-1458-7108
Pawel Piatkowski *International Institute of Molecular and Cell Biology, Warsaw, Poland.
Salla E ToikkanenNational Institute for Health and Welfare, Helsinki, Finland.
V P NagrajSchool of Medicine, Research Computing, University of Virginia, Virginia, USA.ORCID 0000-0003-0060-566X
Christl A DonnellyMRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College, London, W2 1PG, UK.
Thibaut JombartMRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College, London, W2 1PG, UK.ORCID 0000-0003-2226-8692

Funding

Medical Research Council MR/R015600/1
6 · The paper itself

Abstract

As international travel increases worldwide, new surveillance tools are needed to help identify locations where diseases are most likely to be spread and prevention measures need to be implemented. In this paper we present

Indexed as

TravelBrazilDisease OutbreaksHumansRisk AssessmentTravel-Related Illnessdisease surveillanceepidemicsinfectiousoutbreaksRRECON

Identifiers

PMID31543947
PMCPMC6738191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.